http://www.biospace.comBioSpace RSS GeneratorWed, 19 Jun 2013 14:15:51 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.globenewswire.com/news-release/2013/06/19/555065/10036818/en/Raptor-s-PROCYSBI-TM-Now-Commercially-Available-in-the-U-S-for-Nephropathic-Cystinosis-Patients.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>NOVATO, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI (cysteamine bitartrate) delayed-release capsules are now available in the U.S. for shipment...Wed, 19 Jun 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-06-17/novo-drops-as-new-lilly-drug-threatens-victoza-copenhagen-mover.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Novo Nordisk A/S (NOVOB) fell the most among benchmark stocks in Copenhagen trading after Bank of America Merrill Lynch said the diabetes drug companys Victoza medicine faces a real threat from an Eli Lilly...Tue, 18 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=300237&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DEERFIELD, Ill.</span> and <span class"xn-location">OSAKA, Japan</span>, <span class"xn-chron">June 17, 2013</span> /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary...Mon, 17 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=300149&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p /><p><span class"xn-location">HORSHAM, Pa.</span>, <span class"xn-chron">June 14, 2013</span> /PRNewswire/ -- Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick...Mon, 17 Jun 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-06-13/pfizer-s-two-new-top-pills-selling-slower-than-expected.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Pfizer Inc. (PFE)s touted two new drugs arent selling as fast as the company anticipated, a top executive said today, though the drugmaker expects the pills should still become blockbusters. Eliquis, a blood...Fri, 14 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=300100&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">BRISBANE, Calif.</span>, <span class"xn-chron">June 14, 2013</span> /PRNewswire/ --InterMune, Inc. (NASDAQ: ITMN) today announced that the Board of the...Fri, 14 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=300104&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">HORSHAM, Pa.</span>, <span class"xn-chron">June 14, 2013</span> /PRNewswire/ -- Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine...Fri, 14 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=299956&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">SOMERSET, N.J.</span>, <span class"xn-chron">June 12, 2013</span> /PRNewswire/ --GAVIS Pharmaceuticals, LLC announced today that it has launched <span class...Thu, 13 Jun 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130613005088&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. announced today that NAMENDA XR(TM) (memantine hydrochloride) once-daily formulation is now available in pharmacies throughout the United States. NAMENDA...Thu, 13 Jun 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130612006343&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CHARLOTTETOWN, Prince Edward Island--(BUSINESS WIRE)--Neurodyn Inc. announced the North American launch of NeuroPro (10% triterpenoid saponin) supplement. Available online through www.neuroprohealth.com, NeuroPro...Thu, 13 Jun 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/06/11/553386/10035978/en/ACETO-Subsidiary-Rising-Pharmaceuticals-to-Launch-the-Authorized-Generic-Version-of-Covis-Pharma-S-a-r-l-s-Rilutek-R.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PORT WASHINGTON, N.Y., June 11, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and...Wed, 12 Jun 2013 12:00:00 AM GMThttp://www.washingtonpost.com/national/health-science/obama-administration-drops-fight-to-keep-age-restrictions-on-plan-b-sales/2013/06/10/a296406e-d22a-11e2-a73e-826d299ff459_story.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>The Obama administration will scrap age restrictions on the sale of emergency contraception pills, making the morning-after pill available to women and girls without a prescription.<br><br>Help employers...Tue, 11 Jun 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-06-10/abbott-doubled-niaspan-u-s-sales-before-trials-cut-use.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Abbott Laboratories (ABT) aggressively promoted its Niaspan cholesterol treatment, almost tripling U.S. use of the medication, in the seven-year period before studies in 2011 found the drug ineffective, a study...Tue, 11 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=299554&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>LEUVEN, BELGIUM--(Marketwired - June 07, 2013) - TiGenix (NYSE Euronext: TIG), the European leader in cell therapy, today provided an update on the commercial prospects of ChondroCelect...Mon, 10 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=299451&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">SAN DIEGO</span>, <span class"xn-chron">June 7, 2013</span> /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported today on the launch of...Mon, 10 Jun 2013 12:00:00 AM GMThttp://www.philly.com/philly/business/20130604_FDA_weighs_lifting_restrictions_on_Glaxo_s_Avandia.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug Avandia...Thu, 06 Jun 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=299176&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>MORRISVILLE, NC--(Marketwired - June 05, 2013) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http:/...Wed, 05 Jun 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/06/04/551941/10035163/en/ACETO-Subsidiary-Rising-Pharmaceuticals-Launches-Generic-Version-of-Nasalide-R.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PORT WASHINGTON, N.Y., June 4, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance...Tue, 04 Jun 2013 12:00:00 AM GMThttp://www.pharmalive.com/a-premature-death-kv-pharma-and-makena-make-an-unexpected-comebackStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Ever since the scandal erupted over compounding pharmacies and a national outbreak of fungal meningitis, KV Pharmaceuticals has been telling the FDA we told you so. Now, the drugmaker, which landed in bankruptcy...Mon, 03 Jun 2013 12:00:00 AM GMThttp://www.forbes.com/sites/matthewherper/2013/05/29/biogen-idecs-ms-drug-launch-is-going-amazingly-well-these-two-graphs-prove-it/Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Biogen Idec shares are up 60% since I profiled the company in Forbes in December. The reasons pretty simple: sales of the MS drug Tecfidera are basically destroying what were already very high expectations...Fri, 31 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/31/551198/10034697/en/Charles-Hensley-Ph-D-Inventor-of-Zicam-r-Cold-Remedy-And-Itonis-Pharmaceuticals-Prepared-to-File-for-the-National-Drug-Code-Number-for-the-Emesyl-tm-Anti-Nausea-Products-to-Launch-.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Laguna Hills, California, May 31, 2013 (GLOBE NEWSWIRE) -- Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased...Fri, 31 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/sacre-bleu-european-agency-rebuffs-french-regulator-over-bayer-acne-pillStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Now what will French authorities do? After months of debate, the European agency that coordinates regulation of medicines on the continent has decided that the controversial Diane 35 acne pill sold by Bayer...Thu, 30 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/30/550858/10034521/en/Charles-Hensley-Ph-D-Inventor-of-Zicam-r-Cold-Remedy-And-Itonis-Pharmaceuticals-Finalized-Product-Packaging-For-The-Emesyl-Anti-Nausea-Products.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Laguna Hills, California, May 30, 2013 (GLOBE NEWSWIRE) -- Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased...Thu, 30 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=298231&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">IRVINE, Calif.</span>, <span class"xn-chron">May 29, 2013</span> /PRNewswire/ --<b> ChromaDex Corporation</b> (OTCBB: <b>CDXC</b>) ("ChromaDex...Wed, 29 May 2013 12:00:00 AM GMThttp://www.japancorp.net/portal/biospace/index.asp?id=26782Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tokyo, May 28, 2013 (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch antiepileptic agent Inovelon(R) Tablets 100 mg and 200 mg (rufinamide) in Japan on May 29 as an adjunctive therapy to...Tue, 28 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=298078&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LEUVEN, Belgium, May 27, 2013 /PRNewswire/ --</p><p>Roll out in Finland and Norway to follow shortly</p><p>ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused...Tue, 28 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/how-much-abbvie-raises-niaspan-price-despite-study-failuresStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue generated by the pill using a simple business proposition the drugmaker...Fri, 24 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130523005608&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>The Swedish Dental and Pharmaceutical Benefits Agency, TLV has decided to fully reimburse Dymista. Dymista is a prescription drug for the treatment of seasonal and perennial allergic rhinitis and studies have...Thu, 23 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297477&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">ROSEMONT, Pa.</span>, <span class"xn-chron">May 21, 2013</span> /PRNewswire/ -- Duchesnay <span class"xn-location">USA</span>, the first pharmaceutical...Tue, 21 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297485&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">ATLANTA</span>, <span class"xn-chron">May 21, 2013</span> /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced...Tue, 21 May 2013 12:00:00 AM GMThttp://www.latimes.com/news/nationworld/nation/la-na-anthrax-resistant-20130519-dto,0,3192936.htmlstoryStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax...Mon, 20 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297241&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PRLog (Press Release) - May 19, 2013 - NEW YORK -- Immune Response BioPharma, Inc. Sets Pricing of REMUNE Vaccine in Thailand in the range of Between $75-100 Per Dose for Emergency Approval of HIV/AIDS Vaccine...Mon, 20 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297135&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">CHAMPAIGN, Ill.</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130517005141&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that shipments of Horizant (gabapentin enacarbil) Extended-Release Tablets to its distributor in the United States have commenced...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130517005418&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig (zolmitriptan) tablets...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297128&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">PITTSBURGH</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296804&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p /><p /><p><span class"xn-location">PITTSBURGH</span>, May 15, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received...Wed, 15 May 2013 12:00:00 AM GMThttp://www.washingtonpost.com/business/merck-glaxo-health-groups-bringing-cervical-cancer-vaccines-to-girls-in-poorest-countries/2013/05/09/aa1ef328-b89c-11e2-b568-6917f6ac6d9d_story.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Merck & Co. (MRK) and GlaxoSmithKline Plc (GSK) will cut the prices of their cervical cancer vaccines for some countries in the first large-scale effort to get the shots to girls in the worlds poorest regions...Thu, 09 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/non-profit-to-bayer-withdraw-false-vitamin-claims-or-elseStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Threatening another showdown over product claims, a non-profit group has put Bayer on notice that a lawsuit will be filed charging the drugmaker with making unsubstantiated and illegal claims about the ability...Thu, 09 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295935&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>9th May 2013, Billerica, MA and London, UK EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and Plasticell of London, UK, today announced the availability of OsteoMAX-XF, the...Thu, 09 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130509005227&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has been awarded a significant portion of the UNICEF human papillomavirus...Thu, 09 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130507007122&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV- News), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that ILUVIEN...Wed, 08 May 2013 12:00:00 AM GMThttp://www.washingtonpost.com/business/pfizer-sells-viagra-on-its-website-in-a-drug-industry-first/2013/05/06/80382cc4-b61b-11e2-b568-6917f6ac6d9d_story.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill. In a first for the drug industry, Pfizer Inc. told The Associated Press that the...Tue, 07 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/07/544976/10031700/en/Kraig-Biocraft-Laboratories-Announces-Plans-to-Launch-Initial-Commercial-Production-of-Monster-Silk-TM.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LANSING, Mich., May 7, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the leading developer of advanced spider silk based fibers, today announced plans to launch its...Tue, 07 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/06/544692/0/en/Biotie-Selincro-launched-in-the-United-Kingdom.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launchedSelincro in the United Kingdom. According to the terms of the license agreementbetween Biotie and Lundbeck for Selincro, Biotie...Mon, 06 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295485&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br<div id"releaseBody"><p>TURKU, FINLAND--(Marketwired - May 06, 2013) - Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the...Mon, 06 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/novartis-probes-japanese-scandal-over-diovan-researchStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>The scandal over clinical trials generated by Japanese researchers for the Diovan blood pressure drug sold by Novartis has now widened. The drugmaker has now acknowledged publicly for the first time that...Fri, 03 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295292&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">LAVAL, Quebec</span>, <span class"xn-chron">May 2, 2013</span> /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced...Fri, 03 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295301&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Brentwood, May 3 2013: Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Prenoxad Injection, the worlds first licensed emergency...Fri, 03 May 2013 12:00:00 AM GMThttp://www.sacbee.com/2013/05/01/5388457/thrombogenics-jetrea-available.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> LEUVEN, Belgium, May 2, 2013 -- /PRNewswire/ --</p><p>ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic...Thu, 02 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294989&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Brentwood, May 1 2013: Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Tapclob 5mg/5ml and Tapclob 10mg/5ml Oral Suspension...Wed, 01 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/01/543345/10030821/en/Sigma-Tau-Pharmaceuticals-Launches-CYSTARAN-TM-for-the-Treatment-of-Corneal-Cystine-Crystal-Accumulation-in-Patients-With-Cystinosis.htmlStaying up-to-date has never been simpler. Sign up for <a href"http://www.hcareers.com/newsletter/public?intcidseo-article-news-signup&intcidseo-article-news-signup">free job search tips</a>!<br><br>GAITHERSBURG, Md., May 1, 2013 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau), a part of the Sigma-Tau Group Rare Disease Franchise, announced today the availability of CYSTARAN...Wed, 01 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130501005185&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostic radiopharmaceuticals...Wed, 01 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294814&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">PORTLAND, Maine</span>, <span class"xn-chron">April 29, 2013</span> /PRNewswire/ -- Putney, Inc., a rapidly growing pharmaceutical company focused on the...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294877&full=1April 30, 2013, Billerica, MA and London, UK - EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and Plasticell of London, UK, today announced the availability of OsteoMAX-XF, the first fully defined, xeno-free human mesenchymal stem cell differentiation medium for the differentiation of mesenchymal stem cells into osteocytes. Mineralization can be detected in less than...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294685&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><b> </b></p><p><span class"xn-location">ATLANTA</span>, <span class"xn-chron">April 29, 2013</span> /PRNewswire/ -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294249&full=1<div id"releaseBody"><p>CHARLESTON, SC--(Marketwired - April 24, 2013) - The recent commercial coverage of a new oral contraceptive heralds a possible shift in the market toward low-cost pharmaceuticals. <p>Afaxys Pharmaceuticals (<a href"http://www.afaxys.com/pharma">www.afaxys.com/pharma</a>) received FDA approval in December 2012 for its first AB rated monophasic oral contraceptive...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294112&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">MISSISSAUGA, ON</span>, <span class"xn-chron">April 23, 2013</span> /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated...Tue, 23 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294166&full=1NEW YORK, April 23, 2013Zytiga (abiraterone acetate, Janssen) is now the most used first-line treatment in Stage IV prostate cancer patients in the United States, according to new findings from CancerMPact Monthly Drugs and Regimens, which reports oncology drug use by tumor type, stage of disease and line of therapy. The U.S. Food and Drug Administration (FDA) approved Zytiga to treat men with late...Tue, 23 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293991&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>TURKU, FINLAND--(Marketwired - April 22, 2013) - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 April 2013 at 9:00 a.m.<p><b>Biotie: Selincro launched in first European...Mon, 22 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130418_1by Richard Daverman, PhD</p><p>April 18, 2013 -- Cipla Ltd., an Indian generic drug company, has begun marketing a biosimilar version of the rheumatoid arthritis treatment Enbrel, which it sources from Shanghai CP Guojian Pharmaceutical Co. CPGJ has been selling the drug in China since 2006, where it has been given to more than 50,000 patients. Cipla described its relationship with CPGJ as a ...Fri, 19 Apr 2013 12:00:00 AM GMThttp://www.usatoday.com/story/news/nation/2013/04/16/fda-blocks-generic-oxycontin/2089325/In a major policy move, the Food and Drug Administration said Tuesday that it would not approve generic versions of the powerful narcotic OxyContin, the painkiller that symbolized a decade-long epidemic of prescription drug abuse. The move represents a victory for OxyContins manufacturer, Purdue Pharma, which in 2010 introduced a formulation of the drug that was less prone to tampering. The original...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.outsourcing-pharma.com/Contract-Manufacturing/GSK-s-Contract-Manufacturing-Delays-Cause-Shortage-of-Restless-Leg-Treatment?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyrightThe FDA announced a shortage of Horizant (gabapentin enacarbil; GlaxoSmithKline) 600mg extended-release tablets. Horizant is a prodrug of gabapentin that is indicated for postherpetic neuralgia and for moderate-to-severe primary restless legs syndrome in adults. GlaxoSmithKline is currently experiencing a backorder situation. XenoPort will assume manufacturing and commercialization of Horizant from...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293496&full=1MOUNTAIN VIEW, Calif.</span>, <span class"xn-chron">April 16, 2013</span> /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved its amendment and modification to the Risk Evaluation and Mitigation Strategy (REMS) for Qsymia(phentermine and topiramate extended-release) capsules CIV. The amendment, submitted in <span class...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.pmlive.com/pharma_news/ema_recommends_heart_risk_restriction_for_serviers_protelos_471361EMA advisors have called for a restriction on the use of Servier's osteoporosis drug Protelos/Osseor (strontium ranelate) after linking it to serious potential side effects. The move comes after their analysis of clinical trial data showed an increased risk of heart problems, including heart attack. The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) said the key data came from studies involving...Mon, 15 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293183&full=1MUMBAI, India and BALTIMORE, April 12, 2013 /PRNewswire/ --Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its Daysee Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15 mg/0.03 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg) from the United States Food and Drugs Administration (US FDA) to...Fri, 12 Apr 2013 12:00:00 AM GMThttp://www.thehindubusinessline.com/companies/dr-reddys-labs-withdraws-muscle-relaxant-drug-from-us-market/article4606133.eceDr Reddys Laboratories has initiated recall of its tizanidine tablets, used as a muscle relaxant, from the US market due to labelling issues. According to a notification issued by United States Food and Drug Administration (FDA), the recall has been initiated voluntarily by the drug maker and the same was intimated to the drug regulator through a letter on March 19. Tizanidine is a drug that is used...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293104&full=1<div id"releaseBody"><p>BRIDGEWATER, NJ--(Marketwired - April 11, 2013) - Aptalis Pharma, US Inc. announced that its French sister company, Aptalis Pharma SAS, has launched PYLERA<b>&#174;</b> to healthcare professionals in France. PYLERA, in combination with omeprazole, is indicated for the eradication of Helicobacter pylori (H. pylori), and prevention of relapse of peptic ulcers in patients...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293088&full=1LEUVEN, Belgium, April 11, 2013 /PRNewswire/ --</p><p> First EU JETREA(R) order triggers EUR45 million milestone payment from Alcon to ThromboGenics </p><p> ThromboGenics NV (Euronext : THR), an integrated biopharmaceutical company focusedon developing and commercializing innovative ophthalmic and oncology medicines, todayannounces that...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292946&full=1Porton Down, UK; 10 April 2013: GW Pharmaceuticals, the biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, announced that Sativex, its treatment for spasticity in Multiple Sclerosis, has today been rescheduled in the UK from Schedule 1 under the Misuse of Drugs Act to Schedule 4, Part 1. The move follows...Wed, 10 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292649&full=1<div id"releaseBody"><p>SANDY, UT--(Marketwired - April 08, 2013) - Rafarma Pharmaceuticals, Inc. (PINKSHEETS: <a href"http://www.marketwire.com/mw/stock.jsp?TickerRAFA">RAFA</a>), a Russia-based multi-product pharmaceutical company producing generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products, today announces that ZAO "Rafarma" has registered...Mon, 08 Apr 2013 12:00:00 AM GMThttp://www.bizjournals.com/triangle/blog/2013/04/biogen-exec-explain-55k-annual-cost.html?ana=otjBiogen Idecs new multiple sclerosis pill is officially in the hands of patients, and they are footing a hefty bill. The pill, dubbed Tecfidera, is priced at $55,000 per year. Biogen (Nasdsaq: BIIB) has hinted at the possibility of manufacturing Tecfidera locally at its leased Eisai facility. In light of that, I asked Richard Francis, senior vice president of U.S. Commercial Operations at Biogen, to...Fri, 05 Apr 2013 12:00:00 AM GMThttp://www.pharmalive.com/novartis-retracted-papers-and-big-selling-drugA simmering controversy over published research for the Diovan blood pressure drug sold by Novartis and researchers at a Japanese university is heating up. Several papers have already been retracted amid heightened scrutiny over a relationship between the drugmaker and the Kyoto Prefectural University of Medicine, The Mainichi reports. Three papers submitted by university researchers found Diovan...Tue, 02 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/03/29/us-biogen-tecfidera-idUSBRE92S0D720130329Biogen Idec Inc said on Friday it will charge $54,900 a year for its multiple sclerosis drug, Tecfidera, which received U.S. approval on Wednesday. The company has priced the drug at a discount to key competitors such as Novartis AG's MS pill Gilenya, which costs roughly $60,000 a year, in a bid to maximize its market share. "We think this represents solid value to the MS community and demonstrates...Tue, 02 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130329005093&newsLang=enHYDERABAD, India--(BUSINESS WIRE)--Dr. Reddys Laboratories (NYSE: RDY) announced today that it has launched Zenatane (Isotretinoin Capsules USP) in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane (Isotretinoin Capsules USP) in the US market on March 28, 2013 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddys ANDA for Zenatane...Fri, 29 Mar 2013 12:00:00 AM GMThttp://www.pmlive.com/pharma_news/nice_pfizers_lung_cancer_drug_xalkori_too_expensive_for_nhs_469241Patients in England and Wales with lung cancer should not have access to Pfizer's Xalkori through the NHS at the drug's current price, according to new draft guidance from cost-effectiveness body the National Institute for Health and Clinical Excellence (NICE). NICE said that despite being a clinically effective treatment, Xalkori (crizotinib) was not a cost-effective use of NHS resources for use in...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291807&full=1 <div class"xn-content"><p><span class"xn-location">SAN ANTONIO</span>, <span class"xn-chron">March 27, 2013</span> /PRNewswire/ --<b> </b>For years, physicians have prescribed Prednisolone (pred NIS oh lone) in a 15 mg/5 mL standard as a rescue medicine to treat severe asthma attacks, especially in children. Unfortunately, its taste has been so unpleasant the patient often vomits after swallowing...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291831&full=1<div id"releaseBody"><p>LEIDEN, THE NETHERLANDS--(Marketwire - March 28, 2013) - Leiden, the Netherlands, March28th, 2013. Biotech company Pharming Group NV("Pharming") (EURONEXT BRUSSELS: PHARM) announced today that it hasreceivedapproval from the European Medicines Agency (EMA) for Sanofi Chimie tomanufacture drug substance for Pharming's product Ruconest&#174; at theirAramon...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/03/25/us-pfizer-tuberculosis-idUSBRE92O0MO20130325The Food and Drug Administration has added Pfizer Inc's tuberculosis treatment rifampin to its list of drugs in short supply, the latest in a growing number of spottily available TB medications. The FDA noted in a post on its website on Monday that the injectible antibiotic will be in short supply until the end of June. The cause of the shortage is a manufacturing delay, it said. Rifampin is one of...Wed, 27 Mar 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130326005819&newsLang=enINGELHEIM, Germany--(BUSINESS WIRE)--A new perspective from the U.S. Food and Drug Administration (FDA) published in the New England Journal of Medicine1 states that the agency has not changed its recommendations regarding Pradaxa (dabigatran etexilate), following the November 2012 Mini-Sentinel evaluations.2 The FDA stated that bleeding rates associated with new use of Pradaxa do not appear to be...Tue, 26 Mar 2013 12:00:00 AM GMT